Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Low Risk

Score: 15/100

Failure Rate

0.0%

0 terminated/withdrawn out of 9 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

44%

4 trials in Phase 3/4

Results Transparency

50%

4 of 8 completed trials have results

Key Signals

4 with results

Enrollment Performance

Analytics

Phase 3

4(44.4%)

Phase 2

3(33.3%)

Phase 1

2(22.2%)

9Total

Phase 3(4)

Phase 2(3)

Phase 1(2)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (9)

Showing 9 of 9 trials

NCT04683627Phase 3Completed

A 12-week Study to Evaluate the Efficacy and Safety of HP-5000 in Subjects With Osteoarthritis Pain of the Knee

Role: lead

NCT01711021Phase 2Completed

Study to Evaluate Safety & Efficacy of d-Amphetamine Transdermal System vs Placebo in Children & Adolescents With ADHD

Role: lead

NCT04882319Phase 1Completed

Irritation and Sensitization Study of HP-5000 Topical System

Role: lead

NCT03277066Phase 2Completed

A 4-week Study to Evaluate the Efficacy and Safety of HP-5000 in Subjects With Knee Osteoarthritis

Role: lead

NCT04624867Phase 1Unknown

Study Will Assess Skin Irritation and Sensitization for HP-1050 Patch

Role: lead

NCT02876900Phase 3Completed

Study to Assess Efficacy and Safety of HP3070 in Subjects Diagnosed With Schizophrenia.

Role: lead

NCT00151957Phase 3Completed

Safety and Tolerability of SPD485 in Children Aged 6-12 Diagnosed With ADHD and Previously Participated in MTS Trials

Role: collaborator

NCT00151970Phase 2Completed

Efficacy, Safety and Tolerability of SPD485 in Children Aged 6-12 Diagnosed With ADHD

Role: collaborator

NCT00151983Phase 3Completed

Safety & Tolerability of MTS in Children Aged 6-12 Diagnosed With ADHD & Previously Treated With Extended-Release Methylphenidate Therapy

Role: collaborator

All 9 trials loaded